SCHEMBL6618951

SCHEMBL6618951

Cc1ncccc1-n1c(C=Cc2cscn2)nc2ccc(F)cc2c1=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6618424 0.89
SCHEMBL6614081 0.89
SCHEMBL6614084 0.89
SCHEMBL6614814 0.85
SCHEMBL6614818 0.85
SCHEMBL6615375 0.83
SCHEMBL6615374 0.83
SCHEMBL6618407 0.83 MEN1 (0.48)
SCHEMBL6618409 0.83 MEN1 (0.48)
SCHEMBL6616545 0.83 TP53 (0.63)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0964860-B1 ATROPISOMERS OF 3-HETEROARYL-4(3H)-QUINAZOLINONES FOR THE TREATMENT OF NEURODEGENERATIVE AND CNS-TRAUMA RELATED CONDITIONS PFIZER PROD INC (US) 2004-04-21 EP disclosed
US-6380204-B1 ALPHA-AMINO-3-HYDROXY-5-METHYL-4-ISOXAZOLEPROPIONIC ACID RECEPTOR ANTAGONIST ACTIVITY PFIZER INC 2002-04-30 US disclosed
EP-0964860-A1 ATROPISOMERS OF 3-HETEROARYL-4(3H)-QUINAZOLINONES FOR THE TREATMENT OF NEURODEGENERATIVE AND CNS-TRAUMA RELATED CONDITIONS Pfizer Products Inc. (US) 1999-12-22 EP disclosed
WO-1998038187-A1 ATROPISOMERS OF 3-HETEROARYL-4(3H)-QUINAZOLINONES FOR THE TREATMENT OF NEURODEGENERATIVE AND CNS-TRAUMA RELATED CONDITIONS PFIZER PRODUCTS INC. (US) 1998-09-03 WO disclosed